Neurology and Therapy View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2012

PUBLISHER

Springer Healthcare

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/40120

Recent publications latest 20 shown

  • 2019-04-12 Exercise in Multiple Sclerosis: Knowing is Not Enough-The Crucial Role of Intention Formation and Intention Realization.
  • 2019-03-27 Targeting Higher Levels of Tau Protein in Ukrainian Patients with Wilson’s Disease
  • 2019-03-26 PatientConcept App: Key Characteristics, Implementation, and its Potential Benefit
  • 2019-03-22 Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
  • 2019-03-21 Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software Platforms
  • 2019-03-15 An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
  • 2019-03-07 Risperdal® CONSTA® Needle Detachment. Incidence Rates Before and After Kit Redesign: A Retrospective Study using Electronic Health Records and Natural Language Processing in the Department of Veterans Affairs
  • 2019-02-18 Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
  • 2019-01-31 Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes
  • 2019-01-30 Neurology and Therapy: Looking Back on 2018 and Forward to 2019
  • 2019-01-19 Intravenous Milrinone Salvage Therapy in Acute Internal Carotid Artery Occlusion: Case Report
  • 2019-01-08 The Treatment of Hypersalivation in Rett Syndrome with Botulinum Toxin: Efficacy and Clinical Implications
  • 2018-12-18 Treatment Patterns, Healthcare Resource Utilization, and Costs Among Medicare Patients with Multiple Sclerosis in Relation to Disease-Modifying Therapy and Corticosteroid Treatment
  • 2018-12-11 Emerging Immunotherapies for Parkinson Disease
  • 2018-12 European and American Guidelines for Multiple Sclerosis Treatment
  • 2018-12 Acknowledgement to Authors, Referees, and Readers
  • 2018-12-01 Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
  • 2018-12 Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders
  • 2018-12 Decreased Behavioral Abnormalities After Treatment with Combined Donepezil and Yokukansankachimpihange in Alzheimer Disease: An Observational Study. The Osaki-Tajiri Project
  • 2018-12 Letter to the Editor Regarding: A Comprehensive Review on Copemyl®
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33002", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Internal Medicine", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H36001", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Neurology", 
            "type": "DefinedTerm"
          }
        ], 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.111", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "0.917", 
            "type": "Rating"
          }
        ], 
        "description": "

    Aims and Scope

    Neurology and Therapy aims to provide reliable and inclusive, rapid publication for all therapy related research for neurological indications, supporting the timely dissemination of research with a global reach, to help advance scientific discovery and support clinical practice.

    Neurology and Therapy\u00a0is an international, open access, peer reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of neurological and psychiatric \u00a0therapies, (also covering surgery and devices). Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed.

    The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, case reports, trial designs, communications and letters. The journal is read by a global audience and receives submissions from all over the world.\u00a0Neurology and Therapy\u00a0will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.\u00a0

    Rapid Publication

    The journal\u2019s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted, it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal\u2019s open access model, this allows for the rapid and efficient communication of the latest research and reviews to support scientific discovery and clinical practice.

    Personal Service

    The journal\u2019s dedicated in-house editorial team offer a personal \u201cconcierge service\u201d meaning that authors will always have a personal point of contact able to update them on the status of their manuscript.\u00a0 The editorial team check all manuscripts to ensure that articles conform to the most recent COPE and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.\u00a0We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts.\u00a0\u00a0

    Enhanced Digital Features

    Neurology and Therapy\u00a0is able to publish a range of additional enhanced digital features designed to increase visibility, readership, and the educational value of the content. Every paper is accompanied by a bulleted summary slide, giving a time-efficient overview of the article\u2019s key points for a wider readership. Other types of enhanced digital features are also possible such as slide sets, videos and video abstracts, infographics, podcasts and animations. All enhanced digital features are open access and are peer reviewed to the same high standard as the article itself. They can either be submitted at the same time as the manuscript or can be submitted retrospectively, and there is no additional cost to publish these features.

    By having a choice of media for articles (not limited to text, figures and tables alone), readers may receive information more efficiently, whilst being reassured that the content has undergone the same rigorous peer review as the original article.\u00a0Offering succinct multimedia formats can support time-pressed healthcare professionals in keeping on top of recently published research.

    For questions relating specifically to enhanced digital features, please contact adisdigitalfeatures@springer.com.

    Plain Language Summaries

    Articles published in\u00a0Neurology and Therapy\u00a0can be accompanied by Plain Language Summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances. These summaries can help the content to reach a broader audience thus supporting the effective dissemination of research.

    Peer Review Process

    Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

    At least two extensive reviews are required to make the editorial decision. Where reviews conflict, an Editorial Board Member will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed. Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised, it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor, and authors are welcome to make rebuttals against individual reviewer comments, if appropriate.

    Copyright

    Neurology and Therapy\u00a0is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

    Publication Fees

    Upon acceptance of an article, authors will be required to pay the article processing charge of \u20ac340/ $380 per typeset page, which includes the rapid publication, open access, and other features mentioned above. The journal will consider fee discounts and waivers for developing countries on a case-by-case basis.\u00a0\u00a0

    Contact

    For more information about the journal, including pre-submission enquiries, please contact Kirstie.edwards@springer.com.

    ", "editor": [ { "familyName": "Sabbagh", "givenName": "Marwan Noel", "type": "Person" } ], "id": "sg:journal.1050527", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2193-8253", "2193-6536" ], "license": "Fully Open Access", "name": "Neurology and Therapy", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "50527" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "40120" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2014243514" ] }, { "name": "wos_id", "type": "PropertyValue", "value": [ "2193-8253/NEUROLOGY AND THERAPY" ] }, { "name": "scopus_id", "type": "PropertyValue", "value": [ "21100466855" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101637818" ] } ], "publisher": { "name": "Springer Healthcare", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1050527" ], "sdDataset": "journals", "sdDatePublished": "2021-01-19T05:00", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///pack/app/journals_20190313_sn_only.jsonl", "startYear": "2012", "type": "Periodical", "url": "http://link.springer.com/journal/40120" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1050527'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1050527'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1050527'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1050527'


     

    This table displays all metadata directly associated to this object as RDF triples.

    72 TRIPLES      21 PREDICATES      30 URIs      24 LITERALS      11 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1050527 schema:about sg:ontologies/product-market-codes/H33002
    2 sg:ontologies/product-market-codes/H36001
    3 schema:contentRating N656cfc7793364117910385759b769213
    4 Nf6b01314086849d48ba15f810ee52e85
    5 schema:description <p><b>Aims and Scope</b></p><p><i>Neurology and Therapy</i> aims to provide reliable and inclusive, rapid publication for all therapy related research for neurological indications, supporting the timely dissemination of research with a global reach, to help advance scientific discovery and support clinical practice.</p><p><i>Neurology and Therapy</i> is an international, open access, peer reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of neurological and psychiatric  therapies, (also covering surgery and devices). Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed.</p><p>The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, case reports, trial designs, communications and letters. The journal is read by a global audience and receives submissions from all over the world. <i>Neurology and Therapy</i> will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research. </p><p><b>Rapid Publication</b></p><p>The journal’s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted, it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model, this allows for the rapid and efficient communication of the latest research and reviews to support scientific discovery and clinical practice.</p><p><b>Personal Service<br/></b><br/>The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their manuscript.  The editorial team check all manuscripts to ensure that articles conform to the most recent COPE and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts.  </p><p><b>Enhanced Digital Features</b></p><p><i>Neurology and Therapy</i> is able to publish a range of additional enhanced digital features designed to increase visibility, readership, and the educational value of the content. Every paper is accompanied by a bulleted summary slide, giving a time-efficient overview of the article’s key points for a wider readership. Other types of enhanced digital features are also possible such as slide sets, videos and video abstracts, infographics, podcasts and animations. All enhanced digital features are open access and are peer reviewed to the same high standard as the article itself. They can either be submitted at the same time as the manuscript or can be submitted retrospectively, and there is no additional cost to publish these features.</p><p>By having a choice of media for articles (not limited to text, figures and tables alone), readers may receive information more efficiently, whilst being reassured that the content has undergone the same rigorous peer review as the original article. Offering succinct multimedia formats can support time-pressed healthcare professionals in keeping on top of recently published research.</p><p>For questions relating specifically to enhanced digital features, please contact adisdigitalfeatures@springer.com.</p><p><b>Plain Language Summaries</b></p><p>Articles published in <i>Neurology and Therapy</i> can be accompanied by Plain Language Summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances. These summaries can help the content to reach a broader audience thus supporting the effective dissemination of research.</p><p><b>Peer Review Process</b></p><p>Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.</p><p>At least two extensive reviews are required to make the editorial decision. Where reviews conflict, an Editorial Board Member will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed. Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised, it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor, and authors are welcome to make rebuttals against individual reviewer comments, if appropriate. </p><p><b>Copyright</b></p><p><i>Neurology and Therapy</i> is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.</p><p><b>Publication Fees</b><br/><br/>Upon acceptance of an article, authors will be required to pay the article processing charge of €340/ $380 per typeset page, which includes the rapid publication, open access, and other features mentioned above. The journal will consider fee discounts and waivers for developing countries on a case-by-case basis.  </p><p><b>Contact</b></p><p>For more information about the journal, including pre-submission enquiries, please contact Kirstie.edwards@springer.com.</p>
    6 schema:editor N629c4de846594a8faeb07eb225fd5a8e
    7 schema:inLanguage en
    8 schema:isAccessibleForFree true
    9 schema:issn 2193-6536
    10 2193-8253
    11 schema:license Fully Open Access
    12 schema:name Neurology and Therapy
    13 schema:productId N36cf165b066b488380892b1239c04615
    14 N4d7554e89984427c8b2f8b60b3d80346
    15 N6a6ca756572545a7b49806461d542b12
    16 N9817918631ef4ed7bb65064da2d9f9c8
    17 N9858b4dbdabc43b08bc90137398ac02c
    18 Nbd190d62bc9b4e28b3e1359806e98e51
    19 schema:publisher N28d1f21311474715b90013e6ecaf4fbc
    20 schema:publisherImprint Adis
    21 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1050527
    22 schema:sdDatePublished 2021-01-19T05:00
    23 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    24 schema:sdPublisher N9a92892571cf4127acc5b20d685dfb97
    25 schema:startYear 2012
    26 schema:url http://link.springer.com/journal/40120
    27 sgo:license sg:explorer/license/
    28 sgo:sdDataset journals
    29 rdf:type schema:Periodical
    30 N28d1f21311474715b90013e6ecaf4fbc schema:name Springer Healthcare
    31 rdf:type schema:Organization
    32 N36cf165b066b488380892b1239c04615 schema:name lccn_id
    33 schema:value 2014243514
    34 rdf:type schema:PropertyValue
    35 N392e2e9d5eb54a348426a94b2befc8e8 rdf:first sjr
    36 rdf:rest rdf:nil
    37 N4d7554e89984427c8b2f8b60b3d80346 schema:name springer_id
    38 schema:value 40120
    39 rdf:type schema:PropertyValue
    40 N629c4de846594a8faeb07eb225fd5a8e rdf:first Nc16701d1fd6c48479afe868b7c1c74d5
    41 rdf:rest rdf:nil
    42 N656cfc7793364117910385759b769213 schema:author N392e2e9d5eb54a348426a94b2befc8e8
    43 schema:ratingValue 0.917
    44 rdf:type schema:Rating
    45 N6a6ca756572545a7b49806461d542b12 schema:name dimensions_id
    46 schema:value 50527
    47 rdf:type schema:PropertyValue
    48 N6f7f7e6c72414e81b124bb80af9fa3c7 rdf:first snip
    49 rdf:rest rdf:nil
    50 N9817918631ef4ed7bb65064da2d9f9c8 schema:name wos_id
    51 schema:value 2193-8253/NEUROLOGY AND THERAPY
    52 rdf:type schema:PropertyValue
    53 N9858b4dbdabc43b08bc90137398ac02c schema:name scopus_id
    54 schema:value 21100466855
    55 rdf:type schema:PropertyValue
    56 N9a92892571cf4127acc5b20d685dfb97 schema:name Springer Nature - SN SciGraph project
    57 rdf:type schema:Organization
    58 Nbd190d62bc9b4e28b3e1359806e98e51 schema:name nlm_unique_id
    59 schema:value 101637818
    60 rdf:type schema:PropertyValue
    61 Nc16701d1fd6c48479afe868b7c1c74d5 schema:familyName Sabbagh
    62 schema:givenName Marwan Noel
    63 rdf:type schema:Person
    64 Nf6b01314086849d48ba15f810ee52e85 schema:author N6f7f7e6c72414e81b124bb80af9fa3c7
    65 schema:ratingValue 1.111
    66 rdf:type schema:Rating
    67 sg:ontologies/product-market-codes/H33002 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    68 schema:name Internal Medicine
    69 rdf:type schema:DefinedTerm
    70 sg:ontologies/product-market-codes/H36001 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    71 schema:name Neurology
    72 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...